来自软骨生成素预处理间充质干细胞的外泌体促进慢性肩袖撕裂大鼠模型腱止点再生的软骨形成与胶原成熟
本研究在大鼠慢性肩袖撕裂模型中,比较对照、未处理外泌体(un-Exos)和软骨生成素预处理人骨髓间充质干细胞外泌体(KGN-Exos)局部注射对腱骨愈合的影响。结果显示KGN-Exos组组织学评分更高、胶原II表达增加、胶原I/III比值更高,8周时失败载荷(28.12 ± 2.40 N)和刚度(28.57 ± 2.49 N/mm)为三组最高。结论认为局部注射可缓释KGN-Exos的藻酸钠水凝胶能促进腱止点再生和生物力学性能。
要点
- KGN-Exos和un-Exos均能从藻酸钠水凝胶中持续释放长达96小时。
- KGN-Exos组在4周和8周时组织学评分更高,糖胺聚糖和胶原II表达增加。
- 8周时KGN-Exos组失败载荷和刚度均为三组最高。
核心结论
- 局部注射可缓释KGN-Exos的藻酸钠水凝胶能有效促进软骨形成及胶原成熟与组织化,促进腱止点再生,从而增强肩袖修复后的生物力学性能。
- 作者认为KGN-Exos注射可作为无细胞治疗选择,用于加速慢性肩袖撕裂的腱骨愈合。
研究设计与样本
- 控制性实验室研究,共66只大鼠随机分为对照、未处理外泌体(un-Exos)和KGN-Exos三组,在已建立的慢性肩袖撕裂大鼠模型中行双侧肩袖修复并局部注射纯藻酸钠水凝胶、un-Exos或KGN-Exos藻酸钠水凝胶。
主要发现
- un-Exos和KGN-Exos均能从藻酸钠水凝胶中持续释放长达96小时。
- 体内研究显示un-Exos和KGN-Exos在1周时定位于修复部位。
- KGN-Exos组在4周和8周时组织学评分更高,糖胺聚糖和胶原II表达增加。
- 8周时KGN-Exos组腱骨界面胶原纤维更成熟、组织更好,胶原I/III比值高于对照组和un-Exos组。
- 8周时KGN-Exos组失败载荷(28.12 ± 2.40 N)和刚度(28.57 ± 2.49 N/mm)为三组最高。
临床怎么用
- 作者认为KGN-Exos注射可作为无细胞治疗选择,用于加速慢性肩袖撕裂的腱骨愈合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor tendon-to-bone healing in chronic rotator cuff tears (RCTs) is related to unsatisfactory outcomes. Exosomes derived from mesenchymal stem cells reportedly enhance rotator cuff healing. However, the difficulty in producing exosomes with a stronger effect on enthesis regeneration must be resolved. PURPOSE: To study the effect of exosomes derived from kartogenin (KGN)-preconditioned human bone marrow mesenchymal stem cells (KGN-Exos) on tendon-to-bone healing in a rat model of chronic RCT. STUDY DESIGN: Controlled laboratory study. METHODS: Exosome-loaded sodium alginate hydrogel (SAH) was prepared. Moreover, exosomes were labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide (DiR) or 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate (Dil) for in vivo tracking. Bilateral rotator cuff repair (RCR) was conducted in an established chronic RCT rat model. A total of 66 rats were randomized to control, untreated exosome (un-Exos), and KGN-Exos groups to receive local injections of pure SAH, un-Exos, or KGN-Exos SAH at the repaired site. The presence of DiR/Dil-labeled exosomes was assessed at 1 day and 1 week, and tendon-to-bone healing was evaluated histologically, immunohistochemically, and biomechanically at 4 and 8 weeks. RESULTS: Both un-Exos and KGN-Exos exhibited sustained release from SAH for up to 96 hours. In vivo study revealed that un-Exos and KGN-Exos were localized to the repaired site at 1 week. Moreover, the KGN-Exos group showed a higher histological score and increased glycosaminoglycan and collagen II expression at 4 and 8 weeks. In addition, more mature and better-organized collagen fibers with higher ratios of collagen I to collagen III were observed at 8 weeks in the tendon-to-bone interface compared with those in the control and un-Exos groups. Biomechanically, the KGN-Exos group had the highest failure load (28.12 ± 2.40 N) and stiffness (28.57 ± 2.49 N/mm) among the 3 groups at 8 weeks. CONCLUSION: Local injection of SAH with sustained KGN-Exos release could effectively promote cartilage formation as well as collagen maturation and organization for enthesis regeneration, contributing to enhanced biomechanical properties after RCR. CLINICAL RELEVANCE: KGN-Exos injection may be used as a cell-free therapeutic option to accelerate tendon-to-bone healing in chronic RCT.
引用
- Cai J, Xu J, Ye Z, et al. Exosomes Derived From Kartogenin-Preconditioned Mesenchymal Stem Cells Promote Cartilage Formation and Collagen Maturation for Enthesis Regeneration in a Rat Model of Chronic Rotator Cuff Tear. Am J Sports Med. 2023. PMID: 36917828. doi:10.1177/03635465231155927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。